HOW WOULD A STATE VENTILATOR ALLOCATION GUIDELINE HAVE PERFORMED IN NEW YORK CITY DURING THE 2020 COVID-19 SURGE?

por WALSH, BRANDON, PRADHAN, DEEPAK
Publicado 2021

AN OBSERVATIONAL COHORT STUDY: HOW WOULD RESOURCE ALLOCATION POLICIES PERFORM DURING A SURGE OF PATIENTS WITH COVID-19?

por Walsh, Brandon, Mukherjee, Vikramjit, Uppal, Amit
Publicado 2020

Metformin‐associated lactic acidosis: Moving towards a new paradigm?

por Bicsak, Thomas A., Walsh, Brandon, Fineman, Mark
Publicado 2017

Method‐of‐use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity

por Halseth, Amy, Shan, Kevin, Walsh, Brandon, Gilder, Kye, Fujioka, Ken
Publicado 2016

Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years

por Taylor, Kristin, Gurney, Kate, Han, Jenny, Pencek, Richard, Walsh, Brandon, Trautmann, Michael
Publicado 2011

Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Labe...

por Guerdjikova, Anna I., Walsh, Brandon, Shan, Kevin, Halseth, Amy E., Dunayevich, Eduardo, McElroy, Susan L.
Publicado 2017

Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized tria...

por Henry, Robert R., Frias, Juan P., Walsh, Brandon, Skare, Sharon, Hemming, John, Burns, Colleen, Bicsak, Thomas A., Baron, Alain, Fineman, Mark
Publicado 2018

DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks

por Buse, John B., Drucker, Daniel J., Taylor, Kristin L., Kim, Terri, Walsh, Brandon, Hu, Hao, Wilhelm, Ken, Trautmann, Michael, Shen, Larry Z., Porter, Lisa E.
Publicado 2010